missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human LAR Protein
Click to view available options
Quantity:
50 μg
Unit Size:
50µg
Description
Measured by its binding ability in a functional ELISA. When Recombinant Human LRFN5 Fc Chimera (Catalog # 9385-SA ) is used at 1 μg/mL, the concentration of Recombinant Human LAR that produces 50% optimal binding response is 1.5-9 μg/mL.
Specifications
Specifications
| Accession Number | P10586-2 |
| Characterization | Bioactivity |
| For Use With (Application) | Bioactivity |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with BSA and Trehalose. |
| Gene ID (Entrez) | 5792 |
| Molecular Weight (g/mol) | M.W. (Observed): 114-146 kDa and 14 kDa, reducing conditions; M.W. (theoretical): 136 kDa |
| Quantity | 50 μg |
| Source | Mouse myeloma cell line, NS0-derived human LAR protein Ala27-Glu1251 with a C-terminal 6-His tag, and its proteolyzed forms Ala27-Arg1169 and Gln1170-Glu1251 with a C-terminal 6-His tag |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
| Endotoxin Concentration | <0.10 EU / 1 μg of the protein by the LAL method. |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction